Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Mar/23/2021 60 4
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021 11 0
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/20/2021 12 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Mar/19/2021 81 18
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/23/2021 34 4
Dexamethasone Emergency use authorization Used to treat other disease Other treatment Feb/19/2021 12 1
Tipiracil  Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/09/2021 2 0
MVA/S Potential treatment - pre-clinical evidence Experimental Vaccine Feb/03/2021 1 0
Rupintrivir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/27/2021 2 1
Nelfinavir mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 10 1